IDH1 and central nervous system cancer: As IDH-mutant gliomas produce D-2-HG in high amounts (in the mM range), this molecule then diffuses in paracrine fashion to tumor-infiltrating T cells, which uptake it regardless of their activation status through a solute carrier (SLC) transporter.